ASTRO. US: Cancer patients with limited brain metastases (one to four tumors)
who are ≤50 years old should receive stereotactic radiosurgery (SRS)
without whole brain radiation therapy (WBRT), according to a study
available online, open-access, and published in the March 15, 2015 issue
of the International Journal of Radiation Oncology • Biology • Physics
(Red Journal), the official scientific journal of the American Society
for Radiation Oncology (ASTRO). For patients ≤50 years old who received
SRS alone, survival was improved by 13 percentage points when compared
to those patients ≤50 who received both SRS and WBRT.